The protective effect of recombinant Chinese interferon-γ in pulmonary injury in mice

Zhonghua Jiehe he Huxi Zazhi

Volumn 28, Issue 11, 2005, Pages 760-762

  Huang, Shan Ying ^a   Song, Liang Wen ^a   Liu, Tao ^a   Wang, Qing Ming ^a   Li, Yang ^a   Zhang, Yong ^a   Sun, Li ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Animal testing alternative; Interferon gamma; Mice; Pulmonary fibrosis; Recombinant; Therapy

Indexed keywords

BLEOMYCIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYDROXYPROLINE; RECOMBINANT GAMMA INTERFERON;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE MODEL; HUMAN; LUNG; LUNG INJURY; MALE; METABOLISM; MOUSE;

ANIMALS; BLEOMYCIN; COLLAGEN TYPE I; COLLAGEN TYPE III; DISEASE MODELS, ANIMAL; HUMANS; HYDROXYPROLINE; INTERFERON-GAMMA, RECOMBINANT; LUNG; LUNG INJURY; MALE; MICE; MICE, INBRED C57BL;

EID: 33751249927     PISSN: 10010939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Martelli-Junior H, Cotrim P, Graner E, et al. Effect of TGFβ, Interleukin-6 and IFN-γ on the expression of type I collagen, heat shock protein 47, MMP-1 and MMP-2 by fibroblasts from normal gingival and hereditary gingival fibromatosis. J Periodontol, 2003, 74:296-306.
2. Selman M, Thannickal VJ, Pardo A, et al. Idiopathic pulmonary fibrosis: Pathogenesis and therapeutic approaches. Drugs, 2004, 64:405-430.
3. 1: reversal of TGFβ stimulated collagen production. Graefes Arch Clin Exp Ophlhalmol, 2003, 241:116-124.
4. Bletry O, Somogyi A. Do the interfereons have a antifibrotic action? The internist's point of view. Rev Med Interne, 2002, Suppl 4:511s-515s.
5. Lasky JA, Ortiz LA. Antifibrotic therapy for the treatment of pulmonary fibrosis. Am J Med Sci, 2001, 322:213-221.